9-PAHSA-D9

Code: 860409C-500UG D2-231

General description

PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. In adipocytes, PAHSAs sign...


read more

Your Price
€419.30 500UG
€515.74 inc. VAT
REQUEST

General description

PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes. Avanti has obtained a license from the patent holder to manufacture these products for research use.

9-PAHSA-d9 9-[((13,13,14,14,15,15,16,16,16-d9)palmitoyl)hydroxy]-stearic acid is a deuterated palmitoyl hydroxy-stearic acid wherein the nine protons of palmitoyl are replaced by deuterium. Palmitic acid-9-hydroxy-stearic acid (9-PAHSA)is the most abundantly found fatty acid ester of hydroxy fatty acids (FAHFA).

Packaging

5 mL Clear Glass Sealed Ampule (860409C-1mg)

5 mL Clear Glass Sealed Ampule (860409C-500ug)

assay>99% (TLC)
concentration0.5 mg/mL (860409C-500ug), 1 mg/mL (860409C-1mg)
formliquid
manufacturer/tradenameAvanti Polar Lipids 860409C
packagingpkg of 1 × 1 mL (860409C-500ug), pkg of 1 × 1 mL (860409C-1mg)
shipped indry ice
SMILES stringCCCCCCCCCC(OC(CCCCCCCCCCCC([2H])(C([2H])(C([2H])(C([2H])([2H])[2H])[2H])[2H])[2H])=O)CCCCCCCC(O)=O
storage temp.−20°C
Cas Number1809222-43-2
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.